Avinash Desai

Actinium Pharmaceuticals, Inc.

NIH Rank #17629
  • Early Career

NIH Funding · FY2024

Total Funding
$865.3K
Fiscal year 2024
Grants Awarded
1
Active NIH grants
National Rank
#17,629
Among 57,894 PIs
First NIH Award
2024
Year of first funding

Funding & rank history

NIH funding totals and national rank by fiscal year.

Single fiscal year on record (FY2024): $865.3K across 1 grant · National rank #17629.

Top grants by award amount

Avinash Desai's NIH grant portfolio, ranked by award amount.

  • 5R42CA254685-03R42
    Iomab-ACT: A phase I/II study of 131-I apamistamab targeted lymphodepletion followed by CD19-targeted CAR T-cell therapy for patients with relapsed or refractory B-ALL or DLBCL
    $865.3K
    award amount

Affiliation

Institutions that have administered grants for Avinash Desai.

Affiliated with Actinium Pharmaceuticals, Inc. (NY).

Career milestones

Key NIH funding milestones over time.

  1. 2024
    First NIH Award
    Actinium Pharmaceuticals, Inc.
  2. 2024
    $500K Cumulative Funding

Related investigators

Other NIH-funded PIs frequently associated with Avinash Desai.